Influence
June 8, 2020

Conference sparks discussion about monitoring impact of healthcare AI

A Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) conference on the use of artificial intelligence (AI) in healthcare created a discussion about monitoring the impact of algorithms on care.

During the second day of the conference, Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., made a case for “algorithmovigilance,” which is the systematic monitoring of healthcare algorithms to develop and respond to expected and unexpected effects. He stated he believes this surveillance is necessary to address and correct data biases as well as better understand the generalizability of algorithms.

The panel discussion was the subject of a Healthcare Innovation article.

Read the article

In addition to monitoring the impact of AI, the three-day conference, Artificial Intelligence: Applying Research and Engineering Solutions for Emergent Needs in Healthcare, covered the application of AI in healthcare settings, the necessary building blocks to create effective AI and the future applications of this technology.

More than 500 people from 16 countries signed up to attend.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher